Senior Medical Director

Summittherapeutics
Worldwide Remote
Remote

Who this role is best for

Aimed at senior oncology physicians who oversee global Phase 3 trials and regulatory filings in a fast-growing biopharmaceutical setting.

Best fit for

  • Oncologists with Phase 3 trial design experience seeking a leadership role in global drug development.
    — “oversee global Phase 3 clinical trials a BLA (Biologic Licensing Application) filings
  • Physicians comfortable with cross-functional collaboration across clinical operations and regulatory teams.
    — “work cross functionally with Medical Affairs, Regulatory, Commercial and other functions
  • Candidates with prior mid-sized pharma experience in fast-paced oncology product development.
    — “Prior experience in a mid-sized, fast-growing pharmaceutical environment is preferred

Things to consider

  • Role requires travel for investigator engagements and protocol training.
    — “leading investigator engagements including travel to support face-to-face interaction
  • Must be comfortable working in an intense, fast-paced development environment.
    — “working on product development in an extremely fast-paced and intense environment

How to stand out

  • Highlight experience with regulatory submissions to FDA, EMA, or PMDA.
    — “Coordinate and develop information for reports submitted to FDA, EMA, PMDA
  • Showcase publications or presentations to scientific audiences in oncology.
    — “Contribute to the communication strategy of Summit products via publications
Pace · Fast PacedCollaboration · HighAutonomy · HighDecision Impact · CompanyLevel · Senior

Derived from job-description analysis by Serendipath's career intelligence engine.

What success looks like

  • Develop and execute global Phase 3 clinical trials
  • Support regulatory interactions for product advancement
  • Provide medical insight across discovery to manufacturing
Typical background
Experience in oncology clinical trials

Skills & requirements

Required

Clinical Trial DesignMedical OversightRegulatory InteractionsBiostatisticsClinical OperationsMedical Input

Preferred

Mid-sized, Fast-growing Pharmaceutical Environment Experience

Stack & domain

Clinical TrialsMedical OversightProtocol DesignBiostatisticsRegulatory InteractionsClinical OperationsMedical InputLeadershipCommunicationCollaborationProblem-solvingTeamworkOncologyRegulatory Affairs

About the role

Original posting from Summittherapeutics via Greenhouse

About Summit:

Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.

Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:

Non-small Cell Lung Cancer (NSCLC)

HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.

HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.

HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.

Colorectal Cancer (CRC)

HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.

Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.

Overview of Role: 

We are seeking a physician to serve as a Senior Medical Director to oversee global Phase 3 clinical trials a BLA (Biologic Licensing Application) filings. The incumbent will be primarily responsible for developing and executing an integrated clinical trial programs including protocol design and medical oversight of new or ongoing studies.  They will be responsible for obtaining scientific advisory input, work with biostatisticians for phase 3 design and analyses, support regulatory interactions for product advancement, and work closely with clinical operations to provide advice and decision making regarding medical input to achieve operational excellence.   

The candidate must have demonstrated effective collaborative skills to work across various phases of clinical development and serve as a key medical expert for multiple cross functional teams.  This position will provide medical insight across a myriad of functions from discovery to manufacturing are expected.  Additionally, the Medical Director will play a pivotal role in leading investigator engagements including travel to support face-to-face interaction and protocol training.  Prior experience in a mid-sized, fast-growing pharmaceutical environment is preferred, as this role will be working on product development in an extremely fast-paced and intense environment.   The Medical Director will serve as a leader on one multiple potentially pivotal programs.  

Role and Responsibilities: 

Significant Oncology Experience the role will require expertise in the treatment and management of oncology disease such that knowledge can be applied to the strategy and clinical development of Summit medicines to benefit patients 

Work cross functionally with Medical Affairs, Regulatory, Commercial and other functions to develop the overall product strategy in multiple indications 

Work cross functionally with Clinical Operations, Biometrics, Pharmacovigilance, and other functions to successfully complete clinical development programs leading to BLA approvals 

Lead teams to execute on clinical development goals (clinical trial execution, clinical development strategy, medical affairs planning) 

Manage direct reports or cross functional team members as needed based on team needs 

Contribute to the communication strategy of Summit products via publications, manuscripts, abstracts, posters and scientific presentations 

Making vital contributions on pivotal programs in clinical development program  

Directing human clinical trials, phases 1-3, for lead candidate in development, helping to ensure all clinical development milestones are met including enrollment goals 

Participating in medical review of adverse event reports and monitoring of incoming safety data in conjunction with product safety/pharmacovigilance, including evaluating and escalating safety signals  

Coordinate and develop information for reports submitted to FDA, EMA, PMDA, and  government, regulatory, or partner agencies   

Presentations to various external stakeholders - regulators, governing and harmonization bodies, principle investigators, scientific conference attendees, advisors and opinion leaders  

Knowledge of clinical trial conduct to support operational needs for planning and executing clinical trials, including adherence to protocols, safety reviews, assay development, training, and clinical document review  

Planning, reviewing and editing Clinical Study Reports  

Planning, reviewing and editing publications from the program 

Providing input on the design of clinical studies supporting clinical strategy  

All other duties as assigned 

Experience, Education and Specialized Knowledge and Skills: 

Board certified or eligible MD with hematology/oncology product development and experience across stages of clinical development  

Minimum of 5+ years’ experience in pharmaceutical, biologics, or biotech R&D environment, or in a research environment involving the collection and analysis of human data in the area of hematology/oncology 

Working knowledge of clinical development pathways for hematology/oncology therapeutics in the US and EMA  

Self-starter who will move forward with key initiatives without being prompted, able to perform a myriad of tasks needed to support the clinical development program, possesses a highly entrepreneurial and growth mindset, works collaboratively with cross-functional teams, loves a good mission 

This is the pay for this position

Pay Transparency$253,000—$317,000 USD 

Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.

Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit.

Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.

Source: Summittherapeutics careers (Greenhouse)

Similar roles